Table 2 Summary of the issues addressed in the studies that included a quantitative component. Summarises the research questions addressed in the studies that included a quantitative component, the number of studies asking each question, the location of the studies and number of women represented in combined studies from each location, as well as the median and range of responses to each research question.
From: Implementing chlamydia screening: what do women think? A systematic review of the literature
Research question | Number of studies asking question | Location of studies and number of women in combined studies from each location | Median and range of responses (median calculated by placing the response percentages in value order and finding the middle value) | Ref |
|---|---|---|---|---|
Number of women accepting urine screening for chlamydia | 4 | UK (n = 27470) | 71–83% (median 76%) of women accepted screening for chlamydia by urine | [20, 25, 28, 34] |
Readiness to seek chlamydia screening on partner change | 3 | USA (n = 736) | 28–57% (median 47%) of women reported they currently seek chlamydia screening with partner change; 28–50% reported they are ready to screen on partner change; 11–15% are thinking about being ready to seek screening on partner change and 4–7% are not ready to seek screening on partner change | [13, 16, 22] |
Knowledge of chlamydia | 3 | UK (n = 737) | 60–93% of women had heard of chlamydia, 26–86% knew chlamydia could be asymptomatic and 68–82% were not aware of the consequences of untreated infection. | [17, 19, 38] |
Acceptability of chlamydia screening in different healthcare settings: general practice, family planning clinics, termination of pregnancy clinics, colposcopy clinics, antenatal clinics, youth clinics, infertility clinics, genitourinary medicine clinics, gynaecology clinics | 2 | UK (n = 22126) | Acceptability of chlamydia screening in these healthcare settings ranged from 38–100% (median 82%) | [19, 20] |
Acceptability of self administered swab (SAS) vs. first void urine (FVU) vs. pelvic exam and clinician-collected swab for chlamydia screening | 3 | USA (n = 2093) | All 3 studies showed FVU was the preferred method of chlamydia screening over SAS and pelvic examination but FVU and SAS were similar in ease and acceptability. | [27, 29, 30] |
Participation in home screening for chlamydia and preferred test (urine or vaginal swab) | 3 | UK (n = 208), USA (n = 98), Holland (n = 189) | Participation rate in home testing ranged from 31–52% (median 39%). Urine testing was more often accepted than vaginal swab testing: 47–63% relative to 32–37%. | [31–33] |
Rates of partner notification following a diagnosis of chlamydia | 2 | UK (n = 73), USA (n = 55) | Both studies report a 75% rate of partner notification | [24, 25] |